Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page
- Check2 days agoChange DetectedA 403 Forbidden message and a Home link appear in place of the study content, indicating the study record could not be displayed.SummaryDifference0.5%

- Check9 days agoChange DetectedThe site now serves the standard study details page after previously displaying a 403 Forbidden error. The erroneous 403 content and the Home link were removed, restoring access to the trial information.SummaryDifference0.5%

- Check16 days agoChange DetectedThe Study Record page now displays a 403 Forbidden error instead of the study content. This change replaces the detailed content with a standard error page and removes the previously listed study information.SummaryDifference22%

- Check37 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5 tag. This reflects a maintenance update to the page's underlying template or scripts and does not alter the study details presented.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4, indicating a minor update to the revision history.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page shows Revision: v3.6.4, updating the previous v3.6.3. This appears to be a small maintenance update rather than a change to study details.SummaryDifference0.0%

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.